News

Dr. Dhaval Shah Establishes Prestigious Scholarship to Foster Future Doctors’ Success

LAS VEGAS, NV / ACCESSWIRE / November 27, 2023 / Esteemed physician Dr. Dhaval Shah proudly introduces the Dr. Dhaval…

2 years ago

Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC)…

2 years ago

GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

New offering provides an all-in-one AI platform optimized for mammography, that seamlessly integrates artificial intelligence (AI) applications from iCAD to…

2 years ago

Cloud DX Reports Positive Third Quarter and Year to Date 2023 Results

Highlights include 32.6% increase in YTD revenue, 52.2% increase in YTD gross profit and 47.5% improvement in Adjusted EBITDA compared…

2 years ago

Impact Fusion International Announces Its First Feedlot Order in Texas

NAPOLEONVILLE, LA / ACCESSWIRE / November 27, 2023 / Impact Fusion International Inc. (OTC PINK:IFUS)The Company is pleased to report…

2 years ago

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Brandon Rice

NEW YORK--(BUSINESS WIRE)--$PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brandon Rice…

2 years ago

Model N Management to Present at the Raymond James 2023 TMT and Consumer Conference

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance today announced that Model N…

2 years ago

Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing

Halifax, Nova Scotia--(Newsfile Corp. - November 27, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")…

2 years ago

Protagonist Announces Two New Phase 3 ICONIC Studies in Psoriasis Evaluating JNJ-2113 in Head-to-Head Comparisons with Deucravacitinib

The ICONIC program now includes four Phase 3 studies evaluating JNJ-2113; Co-primary endpoints for all four studies are PASI-90 and/or…

2 years ago

EchoNous and United Medical Instruments (UMI) Join Forces to Accelerate Kosmos Growth in the USA

REDMOND, WA / ACCESSWIRE / November 27, 2023 / EchoNous, a trailblazer in AI-enabled point-of-care ultrasound (POCUS) technology, is excited…

2 years ago